Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Renner

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
International Journal of Molecular Sciences|December 11, 2025
Feasibility of Patient-Derived 3D Gastrointestinal Stromal Tumour Models as Alternatives for In Vivo Mouse ModelsDina Mönch, Julia Thiel, Meng Dong, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 14, 2014
KLRG1+ NK cells protect T-bet-deficient mice from pulmonary metastatic colorectal carcinomaMuriel Malaisé, Jordi Rovira, Philipp Renner, et al.
Journal of Translational Medicine|July 30, 2011
Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I)Felix C Popp, Barbara Fillenberg, Elke Eggenhofer, et al.
Nature Cancer|May 16, 2025
MCSP<sup>+</sup> metastasis founder cells activate immunosuppression early in human melanoma metastatic colonizationSeverin Guetter, Courtney König, Huiqin Koerkel-Qu, et al.
Transplantation|September 11, 2009
Toward MSC in solid organ transplantation: 2008 position paper of the MISOT study groupMarc H Dahlke, Martin Hoogduijn, Elke Eggenhofer, et al.
Transplantation|July 8, 2010
Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT)Martin J Hoogduijn, Felix C Popp, Anja Grohnert, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
International Journal of Molecular Sciences|December 11, 2025
Feasibility of Patient-Derived 3D Gastrointestinal Stromal Tumour Models as Alternatives for In Vivo Mouse ModelsDina Mönch, Julia Thiel, Meng Dong, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 14, 2014
KLRG1+ NK cells protect T-bet-deficient mice from pulmonary metastatic colorectal carcinomaMuriel Malaisé, Jordi Rovira, Philipp Renner, et al.
Journal of Translational Medicine|July 30, 2011
Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I)Felix C Popp, Barbara Fillenberg, Elke Eggenhofer, et al.
Nature Cancer|May 16, 2025
MCSP<sup>+</sup> metastasis founder cells activate immunosuppression early in human melanoma metastatic colonizationSeverin Guetter, Courtney König, Huiqin Koerkel-Qu, et al.
Transplantation|September 11, 2009
Toward MSC in solid organ transplantation: 2008 position paper of the MISOT study groupMarc H Dahlke, Martin Hoogduijn, Elke Eggenhofer, et al.
Transplantation|July 8, 2010
Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT)Martin J Hoogduijn, Felix C Popp, Anja Grohnert, et al.
Pageof 4